Elder Pharma weighs sale of nutrition business: sources

MUMBAI (Reuters) - Drugmaker Elder Pharmaceuticals is exploring options to sell its nutrition products business, two sources with direct knowledge of the development said. One of the sources said Elder is looking for a valuation of roughly $60 million to $75 million for the business, which includes about 20 brands, and that discussions are at a very early stage. Elder Pharma Joint Managing Director Alok Saxena denied that the company was looking to sell the business. "We are not selling anything, nor are we discussing this with anybody," Saxena said in an emailed reply to a query from Reuters. ... Credit of the story